This work was supported by Wellcome funding to JB [104648]. Work in the Wellcome Centre for Cell Biology is supported by Wellcome core funding [092076]. The authors acknowledge members of the lab for their help: Bella Maudlin, Emanuela Sani, Susanna De Lucas-Arias and Shiney George. The authors would also like to thank Patrick Cramer for the plasmid YEpEBI31111.

<ol>
	<li>Duffy, E. E., Schofield, J. A., Simon, M. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Gaining+insight+into+transcriptome-wide+RNA+population+dynamics+through+the+chemistry+of+4-thiouridine.">Gaining insight into transcriptome-wide RNA population dynamics through the chemistry of 4-thiouridine.</a> Wiley Interdisciplinary Reviews: RNA. 10 (1), e1513 (2018).</li><li>Windhager, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ultrashort+and+progressive+4sU-tagging+reveals+key+characteristics+of+RNA+processing+at+nucleotide+resolution.">Ultrashort and progressive 4sU-tagging reveals key characteristics of RNA processing at nucleotide resolution.</a> Genome Research. 22, 2031-2042 (2012).</li><li>Baptista, T., Devys, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Saccharomyces+cerevisiae+Metabolic+Labeling+with+4-thiouracil+and+the+Quantification+of+Newly+Synthesized+mRNA+As+a+Proxy+for+RNA+Polymerase+II+Activity.">Saccharomyces cerevisiae Metabolic Labeling with 4-thiouracil and the Quantification of Newly Synthesized mRNA As a Proxy for RNA Polymerase II Activity.</a> Journal of Visualized Experiments. (140), e57982 (2018).</li><li>Barrass, J. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transcriptome-wide+RNA+processing+kinetics+revealed+using+extremely+short+4tU+labeling.">Transcriptome-wide RNA processing kinetics revealed using extremely short 4tU labeling.</a> Genome Biology. 16, 282 (2015).</li><li>Burger, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=4-thiouridine+inhibits+rRNA+synthesis+and+causes+a+nucleolar+stress+response.">4-thiouridine inhibits rRNA synthesis and causes a nucleolar stress response.</a> RNA Biology. 10, 1623-1630 (2013).</li><li>Mendoza-Ochoa, G. I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+fast+and+tuneable+auxin-inducible+degron+for+depletion+of+target+proteins+in+budding+yeast.">A fast and tuneable auxin-inducible degron for depletion of target proteins in budding yeast.</a> Yeast (Chichester England). 36 (1), 75-81 (2018).</li><li>Barrass, J. D., Mendoza-Ochoa, G. I., Maudlin, I. E., Sani, E., Beggs, J. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Tuning+degradation+to+achieve+specific+and+efficient+protein+depletion.">Tuning degradation to achieve specific and efficient protein depletion.</a> Journal of Visualized Experiments. , (2019).</li><li>Hobro, A. J., Smith, N. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+evaluation+of+fixation+methods:+Spatial+and+compositional+cellular+changes+observed+by+Raman+imaging.">An evaluation of fixation methods: Spatial and compositional cellular changes observed by Raman imaging.</a> Vibrational Spectroscopy. 91, 31-45 (2017).</li><li>Gustilo, E. M., Vendeix, F. A. P., Agris, P. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=tRNA's+Modifications+Bring+Order+to+Gene+Expression.">tRNA's Modifications Bring Order to Gene Expression.</a> Current Opinion in Microbiology. 11, 134-140 (2008).</li><li>Dolken, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High-resolution+gene+expression+profiling+for+simultaneous+kinetic+parameter+analysis+of+RNA+synthesis+and+decay.">High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay.</a> RNA. 14, 1959-1972 (2008).</li><li>Miller, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dynamic+transcriptome+analysis+measures+rates+of+mRNA+synthesis+and+decay+in+yeast.">Dynamic transcriptome analysis measures rates of mRNA synthesis and decay in yeast.</a> Molecular Systems Biology. 7, 458 (2011).</li><li>Schmitt, M. E., Brown, T. A., Trumpower, B. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+rapid+and+simple+method+for+preparation+of+RNA+from+Saccharomyces+cerevisiae.">A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae.</a> Nucleic Acids Research. 18, 3091-3092 (1990).</li><li>R&#228;dle, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Metabolic+Labeling+of+Newly+Transcribed+RNA+for+High+Resolution+Gene+Expression+Profiling+of+RNA+Synthesis,+Processing+and+Decay+in+Cell+Culture.">Metabolic Labeling of Newly Transcribed RNA for High Resolution Gene Expression Profiling of RNA Synthesis, Processing and Decay in Cell Culture.</a> Journal of Visualized Experiments. (78), e50195 (2013).</li><li>Herzog, V. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Thiol-linked+alkylation+of+RNA+to+assess+expression+dynamics.">Thiol-linked alkylation of RNA to assess expression dynamics.</a> Nature Methods. 14, 1198-1204 (2017).</li><li>Ohrt, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+dissection+of+step+2+catalysis+of+yeast+pre-mRNA+splicing+investigated+in+a+purified+system.">Molecular dissection of step 2 catalysis of yeast pre-mRNA splicing investigated in a purified system.</a> RNA. 19, 902-915 (2013).</li><li>Alexander, R. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=RiboSys,+a+high-resolution,+quantitative+approach+to+measure+the+in+vivo+kinetics+of+pre-mRNA+splicing+and+3&#8242;-end+processing+in+Saccharomyces+cerevisiae.">RiboSys, a high-resolution, quantitative approach to measure the in vivo kinetics of pre-mRNA splicing and 3&#8242;-end processing in Saccharomyces cerevisiae.</a> RNA. 16, 2570-2580 (2010).</li><li>Wallace, E. W. J., Beggs, J. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Extremely+fast+and+incredibly+close:+cotranscriptional+splicing+in+budding+yeast.">Extremely fast and incredibly close: cotranscriptional splicing in budding yeast.</a> RNA. 23, 601-610 (2017).</li><li>Adelman, K., Lis, J. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Promoter-proximal+pausing+of+RNA+polymerase+II:+emerging+roles+in+metazoans.">Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans.</a> Nature Reviews Genetics. 13, 720-731 (2012).</li><li>Preker, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=RNA+Exosome+Depletion+Reveals+Transcription+Upstream+of+Active+Human+Promoters.">RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters.</a> Science. 322, 1851-1854 (2008).</li><li>Aslanzadeh, V., Huang, Y., Sanguinetti, G., Beggs, J. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transcription+rate+strongly+affects+splicing+fidelity+and+cotranscriptionality+in+budding+yeast.">Transcription rate strongly affects splicing fidelity and cotranscriptionality in budding yeast.</a> Genome Research. 28, 203-213 (2018).</li><li>Schofield, J. A., Duffy, E. E., Kiefer, L., Sullivan, M. C., Simon, M. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=TimeLapse-seq:+adding+a+temporal+dimension+to+RNA+sequencing+through+nucleoside+recoding.">TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding.</a> Nature Methods. 15, 221-225 (2018).</li></ol>

The authors have nothing to disclose.

This article presents a protocol for extremely rapid and specific 4tU labelling, for recovery of nascent, newly synthesized RNA from S. cerevisiae after as little as 15 s of labelling, with very low contamination by unlabeled RNA. 
The user should always take care to maintain the integrity of the RNA by use of cold temperatures and DEPC-treated reagents. Streptavidin bead purification is generally reliable; however, the bead buffer is difficult to handle; it must be made freshly, with its components added in the right order, and not chilled or autoclaved. Common failings include the RNA being incompletely dissolved after the precipitation steps, and so being either not biotinylated or otherwise lost during the processing steps. There is extensive troubleshooting help in the supplementary material.
There are some limitations to be aware of in ers4tU. One already mentioned is that 4tU slows growth of the yeast (Figure 1a). Apart from endogenously thiolated RNAs9, only RNAs that have been transcribed during the labelling period can be purified by this method. Polymerases paused on genes throughout the thiolation time will not produce thiolated transcripts that can be purified, although transcripts that are partially labelled due to polymerases entering or leaving a paused state during thiolation can be recovered. Strains that transcribe poorly, either because of mutation or growth conditions, produce little nsRNA, although the techniques used here will nevertheless improve recovery of nsRNA compared to other methods. Longer times and increased culture volumes may be necessary in these strains and conditions. Note that uracil is a good source of nitrogen and so this method should be trialed before being used for studies involving nitrogen starvation.
The ers4tU protocol is particularly useful for analysis of short-lived RNAs, many of which are so rapidly degraded that they cannot be identified without crippling the degradation machinery. Examples include cryptic unstable transcripts (CUTs)4, and short transcripts produced by premature termination or promoter proximal pausing18 and antisense transcription "upstream" from a promoter (PROMPTs)19. The intermediates produced during processing of stable RNA species are also transient but can be enriched using ers4tU transcription4. The ers4tU protocol is therefore exceptional in permitting highly transient RNA species to be analyzed and captured under near physiological conditions, which is a huge advantage over other methods. This technique has been used to study transcription and downstream RNA processing kinetics in RNA polymerase mutants that elongate faster or slower than normal20.
Thiolation is also compatible with RNA-seq and SLAM-seq21, allowing all RNA produced within a very short time window to be characterized in exquisite detail.

RNA has a dynamic nature; soon after it is produced much RNA is rapidly processed and degraded. Currently, most studies of RNA metabolism analyze the total cellular RNA, which is mostly fully processed and at steady state level. This level depends on the balance between the rates of transcription, post-transcriptional maturation and degradation. Analysis of the processes that lead to the steady state equilibrium requires specialized techniques to capture very short-lived RNA species.
Metabolic labelling of RNA with nucleotide analogues such as 4-thiouracil (4tU) or 4-thiouridine (4sU) (see Duffy et al.1 for an excellent review), offers the ability to isolate thio-labelled nascent RNAs and their processing intermediates. However, published protocols involve labelling times of several minutes2,3, which is slow relative to the rate of production of many transcripts. It takes in the order of one minute to transcribe the average yeast gene, so labelling yeast RNA for less than one minute can be considered extremely short. The extremely rapid and specific 4 thiouracil protocol (ers4tU) maximizes the signal to noise ratio by maximizing 4tU incorporation and minimizing the recovery of unlabeled, pre-existing RNA making very short labelling times possible4.
The thio-modified base must be imported into the cells rapidly and in sufficient quantity to efficiently label the newly synthesized RNA (nsRNA). To promote this, cells are grown in uracil-free medium, and expression of an appropriate permease helps to boost 4tU or 4sU uptake (see Table 1 for a list of plasmids that carry suitable permease genes and Supplementary Figure 1). 4tU&#39;s solubility in sodium hydroxide avoids the need for toxic organic solvents required by other nucleotide analogues. Unfortunately, growing cultures for long periods with thio-modified nucleosides at concentrations greater than 50 &#181;M has been observed to disrupt ribosomes5. However, the concentration (10 &#181;M) used here, and the extremely short labelling times, minimize deleterious effects5 (Figure 1a), while still yielding sufficient RNA for analysis.
This technique can be combined with rapid and specific auxin-mediated depletion of a target protein6,7 (Figure 2), referred to as the &#34;&#946;-est AID 4U&#34; protocol, in which &#946;-estradiol regulated expression of the auxin inducible degron (AID) system is combined with 4tU labelling. With the &#946;-est AID 4U approach, a target protein can be depleted and the effect on RNA metabolism closely monitored (Figure 2). The timing is critical; it is advisable to view the accompanying video and pay close attention to Figure 2 and its animated form (see Supplementary Figure 2).
Processing and degradation of RNA must be stopped extremely rapidly for accurate time resolution. This is achieved using methanol at low temperature, which fixes the cell contents very rapidly and degrades the cell membrane while preserving the nucleic acid content8. The RNA extraction should be efficient and not damage the RNA. Mechanical lysis is effective in the absence of chaotropic agents (often these contain thio groups, so should be avoided). Lithium chloride precipitation of RNA is preferred, as tRNAs are less efficiently precipitated. tRNAs are rapidly transcribed and naturally thiolated9, so removing tRNAs reduces competition for the biotinylation reagent. If small, highly structured RNAs are of interest, alcohol-based RNA precipitation methods are recommended.
To recover the thiolated RNA, biotin is covalently attached via the thio groups incorporated into the RNA with 4tU. The use of modified biotin, which attaches via a cleavable disulfide bond (e.g., HPDP-biotin (N-[6-(Biotinamido)hexyl]-3&#180;-(2&#180;-pyridyldithio)propionamide, ) or MTS-biotin (Methane thiosulfonate)) is recommended as it permits release of the RNA by addition of a reducing agent. The biotinylated RNA is affinity purified on streptavidin coupled to magnetic beads. This protocol is similar to others listed previously10 but has been intensively optimized to reduce background.
There are two types of thiol-labelling experiment that can be performed, continuous and discontinuous labelling. Each has its own advantages. In continuous labelling the 4tU is added to the culture and samples taken at regular intervals. This type of experiment shows how the RNA is processed and how levels change over time. Examples include comparison of mutant with wild-type experiments and a pulse-chase experiment. The experiments shown in Figure 3b,c are of this type. For discontinuous labelling a change is induced into the system and the RNA monitored. Once the change has been induced the culture must be split into several sub-cultures, and at specific times, each one is then thio-labelled for a brief period. One example is &#946;-est AID 4U shown in Figure 27. This type of experiment is particularly useful for monitoring the effect of a metabolic change on RNA processing (see Figure 3d).
A graphical representation of a thio-labelling experiment is presented in Figure 4 and Figure 5, and a spreadsheet that greatly simplifies the performance of the protocol is available (see 4tU experiment template.xlsx). As well as this the Supplementary Information contains an extensive troubleshooting guide. For the &#946;-est AID 4U protocol that integrates 4tU labelling with the auxin depletion protocol, see Figure 2 and Supplementary Figure 2. See Barrass et al.7 for the detailed AID depletion protocol.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr >
			<td >&#946;-mercaptoethanol (&#946;ME)</td>
			<td >Sigma-Aldrich</td>
			<td >M3148</td>
			<td >CAUTION toxic. Stock solutions are aproximatly 14 M, make at 1/20 dilution for use</td>
		</tr>
		<tr >
			<td >Chloroform</td>
			<td>Sigma-Aldrich</td>
			<td>25668</td>
			<td>CAUTION toxic</td>
		</tr>
		<tr >
			<td >Diethyl pyrocarbonate (DEPC)</td>
			<td>Sigma-Aldrich</td>
			<td>D5758</td>
			<td>add 1/1000 volume to a solution, leave at room temperature for 24 h, then autoclave</td>
		</tr>
		<tr >
			<td >DMF (N,N-dimethylformamide)</td>
			<td>&#160;Sigma-Aldrich</td>
			<td>227056</td>
			<td>CAUTION toxic</td>
		</tr>
		<tr >
			<td >EDTA</td>
			<td>Sigma-Aldrich</td>
			<td>3609</td>
			<td >Make 0.5 M and pH to 8.0 with sodium hydroxide</td>
		</tr>
		<tr >
			<td >Ethanol</td>
			<td>Sigma-Aldrich</td>
			<td>29221</td>
			<td></td>
		</tr>
		<tr >
			<td >EZ-link HPDP Biotin</td>
			<td>Thermo scientific</td>
			<td>21341</td>
			<td >Store protected from light. Disolve all the vial contents in 22.7 mL DMF (to make a 4 mM stock solution). Store away from water, in the dark &#38; at -20 &#176;C. Check the solution before using, as some batches of HPDP precipitate in storage; heat at 42 &#176;C to resuspend.</td>
		</tr>
		<tr >
			<td >Glucose</td>
			<td >Fisher Scientific&#160;</td>
			<td >G/0500/60</td>
			<td></td>
		</tr>
		<tr >
			<td >Glycogen [20 mg/mL]</td>
			<td>Sigma-Aldrich</td>
			<td>10901393001</td>
			<td>Store at -20 &#176;C</td>
		</tr>
		<tr >
			<td >Immobilised TCEP Disulfide Reducing Gel</td>
			<td>Thermo Scientific</td>
			<td>77712</td>
			<td>Optional</td>
		</tr>
		<tr >
			<td >LiCl</td>
			<td>Sigma-Aldrich</td>
			<td>793620</td>
			<td >10 M solution. CAUTION: this gets very hot as is dissolves and can even boil at greater than 100 oC, add the LiCl crystals to the water slowly.</td>
		</tr>
		<tr >
			<td >Magnesium chloride (MgCl2)</td>
			<td>Sigma-Aldrich</td>
			<td >63033</td>
			<td >1 M solution. CAUTION: this gets very hot as is dissolves and can even boil at greater than 100 oC, add the MgCl2 crystals to the water slowly.</td>
		</tr>
		<tr >
			<td >Methanol</td>
			<td >Fisher Scientific</td>
			<td >M/4000/PC17</td>
			<td >CAUTION Toxic and flammable</td>
		</tr>
		<tr >
			<td >NaH2PO4</td>
			<td>Sigma-Aldrich</td>
			<td>S3139</td>
			<td rowspan="2">Make 1 M solutions of each and mix in equal amount to obtain a solution of the appropriate pH</td>
		</tr>
		<tr >
			<td >Na2HPO4</td>
			<td>Sigma-Aldrich</td>
			<td>S3264</td>
		</tr>
		<tr >
			<td >NaCl</td>
			<td>Sigma-Aldrich</td>
			<td>S9888-M</td>
			<td>5 M solution</td>
		</tr>
		<tr >
			<td >Phenol, low pH.&#160;&#160;</td>
			<td>Sigma-Aldrich</td>
			<td>P4682</td>
			<td>Store in the dark at 4 &#176;C. CAUTION toxic</td>
		</tr>
		<tr >
			<td >Phenol Chloroform 5:1 (125:24:1) low pH.&#160;</td>
			<td>Sigma-Aldrich</td>
			<td>P1944</td>
			<td>Store in the dark at 4 &#176;C. CAUTION toxic</td>
		</tr>
		<tr >
			<td >Pierce Spin Columns</td>
			<td>Thermo Scientific</td>
			<td>69702</td>
			<td>Optional</td>
		</tr>
		<tr >
			<td >SCSM single drop-out &#8211;ura</td>
			<td >Formedium&#160;</td>
			<td >DSCS101</td>
			<td></td>
		</tr>
		<tr >
			<td >Sodium Acetate</td>
			<td>Sigma-Aldrich</td>
			<td>32318-M</td>
			<td>Make a 3 M solution and pH to 5.3 with acetic acid</td>
		</tr>
		<tr >
			<td >Sodium hydroxide</td>
			<td>Sigma-Aldrich</td>
			<td>795429</td>
			<td>CAUTION corrosive</td>
		</tr>
		<tr >
			<td >SDS (Sodium dodecyl sulfate)</td>
			<td>Sigma-Aldrich</td>
			<td >436143</td>
			<td>CAUTION irritant, do not inhale</td>
		</tr>
		<tr >
			<td >Streptavidin Magnetic beads</td>
			<td>NEB</td>
			<td>1420S</td>
			<td>Store at 4&#176;C&#160;</td>
		</tr>
		<tr >
			<td >SUPERase-In, RNase inhibitor</td>
			<td>Life technologies&#160;</td>
			<td>AM2696</td>
			<td>Store at -20&#176;C</td>
		</tr>
		<tr >
			<td >Thiolated Schizosaccharomyces pombe for spike</td>
			<td></td>
			<td></td>
			<td>See section 1.7 of the protocol</td>
		</tr>
		<tr >
			<td >4-thiouracil (4tU)&#160;</td>
			<td>ACROS ORGANICS</td>
			<td>359930010</td>
			<td>Store in the dark. Make 100 mM Stock in 1M NaOH, store solutions at -20&#176;C.&#160;</td>
		</tr>
		<tr >
			<td >Tris base</td>
			<td>Sigma-Aldrich</td>
			<td >93362</td>
			<td>1 M solutions at various pH</td>
		</tr>
		<tr >
			<td >tRNA</td>
			<td>Sigma-Aldrich</td>
			<td>10109541001</td>
			<td>5mg/ml, store at -20&#176;C</td>
		</tr>
		<tr >
			<td >Uridine</td>
			<td>Sigma-Aldrich</td>
			<td>U3750</td>
			<td>Make 1 M solution in H2O. Split into 2 mL aliquots and store at -20 C.</td>
		</tr>
		<tr >
			<td >Yeast nitrogen base without amino acids&#160; with amonium sulphate</td>
			<td >Formedium</td>
			<td >CYN0410</td>
			<td></td>
		</tr>
		<tr >
			<td >Zeba Columns 0.5ml</td>
			<td>Thermo Scientific</td>
			<td>89882</td>
			<td>Store at 4 &#176;C&#160;</td>
		</tr>
		<tr >
			<td >Zirconia beads</td>
			<td>Thistle Scientific</td>
			<td>110791052</td>
			<td ></td>
		</tr>
		<tr >
			<td >Equipment and Consumables</td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr >
			<td >Beadbeater</td>
			<td>Biospec</td>
			<td>112011EUR</td>
			<td >Other homogenisers can be used; the correct conditions for each homogeniser and strain must be established.</td>
		</tr>
		<tr >
			<td colspan="4" >Bioanalyser (Agilent) or similar to assess RNA quality. If this is not important a spectrophotometer is useful to quantify the RNA.</td>
		</tr>
		<tr >
			<td colspan="2" >Centrifuge: capable of spinning cultures at 4 &#176;C and at least 3000 g. Pre-chill if possible.</td>
			<td></td>
			<td></td>
		</tr>
		<tr >
			<td colspan="3" >Centrifuge: capable of spinning up to 2 mL tubes at variable speeds upto 13,000 g and down to 1000 g&#160;</td>
			<td></td>
		</tr>
		<tr >
			<td colspan="4" >Magnetic rack for separating the beads from the sample. The one used in the paper is 3D printed, available from Thingiverse (thing:3562952). Comercially available racks exist&#160;</td>
		</tr>
		<tr >
			<td colspan="2" >PCR machine with a heated lid that will allow incubation in the dark.</td>
			<td></td>
			<td></td>
		</tr>
		<tr >
			<td >Rotating wheel to rotate 1.5 mL tubes end over end&#160;</td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr >
			<td colspan="2" >Shaking heating block (such as Eppendorf Thermomixer) is recomended&#160;</td>
			<td></td>
			<td></td>
		</tr>
		<tr >
			<td >Tubes, centrifuge, Low retention, RNase free 0.5mL</td>
			<td>Eppendorf</td>
			<td>H179467N</td>
			<td></td>
		</tr>
		<tr >
			<td >Tubes, centrifuge, Low retention, RNase free 1.5mL</td>
			<td>Ambion</td>
			<td>AM12350</td>
			<td></td>
		</tr>
		<tr >
			<td >Tubes, centrifuge, 50 mL&#160;</td>
			<td>Sarstedt</td>
			<td>62.547.004</td>
			<td rowspan="2" >Other centrifuge tubes are not gas proof allowing CO2 to disolve in the methanol, this comes out of solution vigorously on adding warm culture, leading to sample loss</td>
		</tr>
		<tr >
			<td >Tubes, centrifuge, 15 mL&#160;</td>
			<td>Sarstedt</td>
			<td>62.554.001</td>
		</tr>
		<tr >
			<td >Tubes, 2 mL, screw cap</td>
			<td>Greiner</td>
			<td>723361</td>
			<td></td>
		</tr>
		<tr >
			<td >Tubes 0.2 mL strip of 8 with integral lids</td>
			<td>Brand</td>
			<td >781332</td>
			<td></td>
		</tr>
	</tbody>
</table>

extremely rapid and specific metabolic labelling of rna in vivo with 4-thiouracil (ers4tu)

The nucleotide analogue, 4-thiouracil (4tU), is readily taken up by cells and incorporated into RNA as it is transcribed in vivo, allowing isolation of the RNA produced during a brief period of labelling. This is done by attaching a biotin moiety to the incorporated thio group and affinity purifying, using streptavidin coated beads. Achieving a good yield of pure, newly synthesized RNA that is free of pre-existing RNA makes shorter labelling times possible and permits increased temporal resolution in kinetic studies. This is a protocol for very specific, high yield purification of newly synthesized RNA. The protocol presented here describes how RNA is extracted from the yeast Saccharomyces cerevisiae. However, the protocol for purification of thiolated RNA from total RNA should be effective using RNA from any organism once it has been extracted from the cells. The purified RNA is suitable for analysis by many widely used techniques, such as reverse transcriptase-qPCR, RNA-seq and SLAM-seq. The specificity, sensitivity and flexibility of this technique allow unparalleled insights into RNA metabolism.

Typical yields for nsRNA recovered using this ers4tU protocol are displayed in Figure 1b, this has been produced by a bioanalyzer and the trace shows yield of RNA versus size (nucleotides [nt]). Note, in both the bioanalyzer trace and the inset graph, that RNA recovery from time point 0 is a very small portion of that recovered from longer time points - approximately 0.3 &#181;g of RNA recovered from approximately 109 cells compared with over twice as much after just 30 s of labelling (0.8 &#181;g of nsRNA) from the same number of cells. RNA recovery at 15 s is more variable as small differences in performing the sampling have a proportionately larger effect on RNA recovery. In the bioanalyzer trace, rRNA precursors can be seen as a peak near 1000 nt and a doublet of peaks at 1700&#8722;1800 nt. The abundance of these intermediates increases as thiolation continues.
Thio-labelling was used to quantify splicing of the ACT1 transcript (Figure 3). Thiolation was performed and samples taken at 15 s intervals from the start of thio-labelling and the processing of ACT1 RNA monitored (Figure 3a,b). As can be seen, pre-mRNA is generated (by transcription), and lariats (by the first step of splicing from pre-mRNA), even after just 15 s of labelling. After about 45 s to 1 min, the amounts of lariats and pre-mRNA reach equilibrium with as much of these RNA species being created by transcription as are processed away by splicing.
To produce the data shown in Figure 3c the strain was pulsed with 4tU for 25 s and then chased with uridine. The generation of pre-mRNA and lariats reaches a maximum at 1 minute. This compares well with Figure 3b; the maximum being achieved after 45 s to reach equilibrium plus the 25 s of the labelling. After the peak, the levels decline as the thio-labelled RNAs are chased through the splicing process.
Figure 3d shows depletion of a protein splicing factor and its effect on RNA metabolism, using the &#946;-est AID 4U system6,7. Here, Prp16p is reduced from near physiological levels to 5% of this level after 25 min of depletion. Prp16p is an essential splicing factor for the second step of splicing15. Lariats are removed during the second step of splicing (Figure 3a), but here they increase above the level of pre-mRNA as Prp16 becomes limiting. At later depletion times, other factors become limiting due to secondary effects, so that levels of lariat decrease, and pre-mRNA levels rise. The level of spliced mRNA declines.
<img alt="Figure 1" class="xfigimg" src="/files/ftp_upload/59952/59952fig1.jpg" /> 
Figure 1: Growth in 4tU and RNA recovery. (a) 4-thiouracil affects growth. Increasing the concentration of 4tU in YMM drop-out growth medium without uracil increases the doubling time of S. cerevisiae (BY4741) carrying the p4Fui&#916;PEST plasmid. Growth of four replicate cultures was monitored at 30 &#176;C in a Tecan Infinite Pro 200. All cultures were in log phase throughout, with OD600 between 0.1 and 0.6. Mock is a control culture with an equivalent amount of NaOH added, which does not by itself change the growth rate. This graph demonstrates that thio-labelling is compromise between rapid labelling and damage to the cell. Error bars are standard error of 4 replicates. (b) nsRNA yield increases linearly from about 15 s of labelling. The main figure shows the bioanalyzer traces of purified, nsRNA from 0 (not thiolated) to 2 min after addition of 4tU at 15 s intervals. Note that the 15 s sample is not shown, as it was indistinguishable from the unlabelled sample. The two large peaks correspond to ribosomal RNAs (rRNAs). The rRNA precursors and intermediates are visible as several peaks at greater molecular weight than mature rRNAs. The recovery of these precursors and intermediates increases with time. Results from one representative experiment are shown. The inset graph shows the recovery of nsRNA with increasing incubation with 4tU. The yield of nsRNA increases with increasing time of growth with 4tU. The recovery is remarkably linear (R2 = 0.934) throughout the timescale of this experiment and shows a slight increase over background even at 15 s labelling with 4tU even though not distinguishable from the unlabelled sample by eye from the bioanalyzer trace. Error bars show standard error for three biological replicates. <a href="https://www.jove.com/files/ftp_upload/59952/59952fig1large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 2" class="xfigimg" src="/files/ftp_upload/59952/59952fig2.jpg" /> 
Figure 2: &#946;-est AID 4U &#946;-est AID 4U graphical protocol. A graphical summary of the protocol of the &#946;-est AID 4U protocol. &#946;-estradiol (&#946;-est) promotes the expression of the auxin inducible degron (AID) system which in turn depletes an AID* tagged target protein, refer to Barrass et al.7 for a detailed protocol. In this case, degron system expression is initiated 25 min before protein degradation commences and thiolation at each time point is for 1 min. Samples are taken before induction and every 2 minutes during depletion. An animated version appears in the Supplementary Figure 2. <a href="https://www.jove.com/files/ftp_upload/59952/59952fig2large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 3" class="xfigimg" src="/files/ftp_upload/59952/59952fig3v2.jpg" /> 
Figure 3: Precursors and intermediates of ACT1 RNA splicing. Splicing of ACT1 pre-mRNA transcripts was monitored by quantitative reverse transcription PCR16. The levels of ACT1 precursor (pre-mRNA), intermediate lariat-exon2 (Lariat) and spliced product (mRNA) are shown normalized against the level of ACT1 Exon2 and steady state levels of these RNAs. (a) Location of qPCR products on the ACT1 transcript. Schematic of the locations of the qPCR products used to assay the levels of precursors, intermediates and products of the splicing reaction of the ACT1 transcripts16. Exons are represented by boxes, intron as a line and the qPCR products as lines with diamonds at either end, the color matches those used in the graphs. The pre-mRNA PCR is specific for pre-mRNA and not any intermediates of splicing as this product crosses the branch point which is disrupted after the first step of splicing. Lariat PCR will detect the product of the first step of splicing and the excised lariat produced after the second. The mRNA PCR is specific for the product of splicing, mRNA. Results from the exon PCR (present in all precursors, intermediates and products, except the excised lariat) is not shown in the graphs as this was used to normalize the data and is therefore always equal to 1. (b) Continuous thiolabelling. The amount of pre-mRNA increases with time as 4tU is incorporated by transcription and, after a short delay, splicing converts it to lariat-exon2 intermediate and spliced products. The levels of these pre-mRNA and lariat species are detectable above background after as little as 15 s of growth with 4tU and reach a maximum after approximately 45 s of continuous labelling with 4tU, at which point their production is balanced by conversion to spliced mRNA and/or degradation. Values are normalized to their steady state (left-most point of the graph), and exon 2 levels to show their appearance and processing in comparison to transcription of exon 2. As RNA splicing of ACT1 is largely co-transcriptional4,17 spliced mRNA rapidly becomes the most abundant species, its level is similar to that of exon 2. Standard error of three biological replicates, each assayed in triplicate. (c) Pulse/chase. Thiolation pulse of 25 seconds followed by chase with uridine. Compared to the steady state levels of these RNAs (left-most point), they are initially very abundant in the newly synthesized pool. The levels gradually decline as they are processed into mRNA (or degraded), approaching levels very similar to steady state levels by 5 min. Standard error of three biological replicates, each assayed in triplicate. (d) nsRNA and protein depletion. Splicing of ACT1 pre-mRNA transcripts monitored by quantitative reverse transcription PCR as in panel (a) upon depletion of the Prp16 protein using the auxin degron system as described in Figure 2. The Prp16 protein levels are also displayed in the graph plotted against the second Y-axis as percentage of levels prior to auxin depletion. Prp16 is a vital component of the spliceosome, particularly important for the second step of splicing shown in panel (a), after which lariats are degraded. When this step becomes limiting lariats accumulate initially. At later time points splicing fails completely, lariats are no longer produced and pre-mRNA levels rise. Error bars are standard error of three biological replicates, each assayed in triplicate. <a href="https://www.jove.com/files/ftp_upload/59952/59952fig3large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 4" class="xfigimg" src="/files/ftp_upload/59952/59952fig4.jpg" /> 
Figure 4: Graphical summary of the protocol sections 1 to 3. The cells are thiolated with 4tU and allowed to grow to incorporate the modified nucleotide into the RNA. A thiolated S. pombe spike can be added to allow normalization across time points and experiments. The pulse of 4tU can be chased using un-thiolated uridine. Labelling can either be performed continuously from 4tU addition or from a change to growth conditions, the culture split and 4tU added to cultures at increasing times from the growth condition change, but each labelling only for a brief time. The cells are collected, and RNA prepared from the cells, preferably using a homogenizer and phenol-based methods. The RNA is biotinylated and then the biotinylated RNA purified from unincorporated biotin using a size exclusion column. The nsRNA is now ready for purification with streptavidin beads (section 4, Figure 5). Numbers in red correspond to the step numbers in the protocol. <a href="https://www.jove.com/files/ftp_upload/59952/59952fig4large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 5" class="xfigimg" src="/files/ftp_upload/59952/59952fig5.jpg" /> 
Figure 5: Graphical summary of the protocol section 4. Following on from sections 1 to 3 (Figure 4), the streptavidin beads are blocked and the biotinylated RNA sample added to the prepared beads. The biotinylated RNA binds to the streptavidin beads and the un-biotinylated RNA removed and washed. The biotinylated RNA is eluted from the beads using &#946;ME and precipitated ready for further research. Numbers in red correspond to the step numbers in the protocol. <a href="https://www.jove.com/files/ftp_upload/59952/59952fig5large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
Supplementary Figure 1: Improvement of nsRNA recovery from yeast cells with and without additional copies of the importer at 1 and 3 minutes of thio-labelling. Note that Fui1 is the yeast&#39;s own promoter expressed from a 2 &#181;m plasmid. The genomic copy of this gene is present in both of these strains. <a href="https://www.jove.com/files/ftp_upload/59952/Figure_S1.ai">Please click here to download this file.</a>
Supplementary Figure 2: Animated version of the &#946;-est AID 4U &#946;-est AID 4U graphical protocol. <a href="https://www.jove.com/files/ftp_upload/59952/Figure_S2_Best-AID_4U.mp4">Please click here to download this file.</a>
Supplementary File 1:&#160;4tU_experiment_template.xltx.&#160;<a href="https://www.jove.com/files/ftp_upload/59952/4tU_experiment_template.xltx">Please click here to download this file.</a>
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Plasmid Name</td>
			<td>Importer/permease</td>
			<td>Marker</td>
			<td>Comment</td>
			<td></td>
		</tr>
		<tr>
			<td>p4Fui</td>
			<td>S. cerevisiae Fui1</td>
			<td>URA3</td>
			<td rowspan="2">Fui1 imports Uracil and Uridine, making it ideal for pulse/chase experiments.</td>
			<td></td>
		</tr>
		<tr>
			<td>pAT2</td>
			<td>S. cerevisiae Fui1</td>
			<td>LEU2</td>
			<td></td>
		</tr>
		<tr>
			<td>p4Fui-&#916;PEST</td>
			<td>S. cerevisiae Fui1</td>
			<td>URA3</td>
			<td>The PEST motif of Fui1 has been deactivated, so the permease is not degraded when there is sufficient intracellular uracil for the cell&#8217;s needs. Works well in labelling experiments and improves pulse/chase performance.</td>
			<td></td>
		</tr>
		<tr>
			<td>p4Fur</td>
			<td>S. cerevisiae Fur4</td>
			<td>URA3</td>
			<td>Uracil permease</td>
			<td></td>
		</tr>
		<tr>
			<td rowspan="2">YEpEBI311</td>
			<td>H. Sapiens ENT1</td>
			<td rowspan="2">LEU2</td>
			<td rowspan="2">Miller et al.11. Also contains an HSV thymidine kinase gene.</td>
			<td></td>
		</tr>
		<tr>
			<td>(equilibrative nucleoside transporter)</td>
			<td></td>
		</tr>
		<tr>
			<td colspan="4">All plasmids are 2 &#181;m based. All p4 plasmids and pAT are based on the pRS16 series of plasmids. FUI1 and FUR4 are expressed from their own, endogenous promoters.</td>
			<td></td>
		</tr>
	</tbody>
</table>
Table 1: Plasmids used with this protocol.

Watch this Scientific Journal Video about Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU at JoVE.com

Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU

The use of thiolated uracil to sensitively and specifically purify newly transcribed RNA from the yeast Saccharomyces cerevisiae.

Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil (Ers4tU)

The nucleotide analogue, 4-thiouracil (4tU), is readily taken up by cells and incorporated into RNA as it is transcribed in vivo, allowing isolation of ...

extremely-rapid-specific-metabolic-labelling-rna-vivo-with-4

Research

JoVE Journal

Biochemistry

10.6K Views.  University of Edinburgh. The use of thiolated uracil to sensitively and specifically purify newly transcribed RNA from the yeast Saccharomyces cerevisiae.

Video: Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU

Highly Sensitive and Rapid Fluorescence Detection with a Portable FRET Analyzer

Recent improvements in F&#246;rster resonance energy transfer (FRET) sensors have enabled their use to detect various small molecules including ions and amino acids. However, the innate weak signal intensity of FRET sensors is a major challenge that prevents their application in various fields and makes the use of expensive, high-end fluorometers necessary. Previously, we built a cost-effective, high-performance FRET analyzer that can specifically measure the ratio of two emission wavelength bands (530 and 480 nm) to achieve high detection sensitivity. More recently, it was discovered that FRET sensors with bacterial periplasmic binding proteins detect ligands with maximum sensitivity in the critical temperature range of 50 - 55 &#176;C. This report describes a protocol for assessing sugar content in commercially-available beverage samples using our portable FRET analyzer with a temperature-specific FRET sensor. Our results showed that the additional preheating process of the FRET sensor significantly increases the FRET ratio signal, to enable more accurate measurement of sugar content. The custom-made FRET analyzer and sensor were successfully applied to quantify the sugar content in three types of commercial beverages. We anticipate that further size reduction and performance enhancement of the equipment will facilitate the use of hand-held analyzers in environments where high-end equipment is not available.

This protocol describes the rapid and highly sensitive quantification of F&#246;rster resonance energy transfer (FRET) sensor data using a custom-made portable FRET analyzer. The device was used to detect maltose within a critical temperature range that maximizes detection sensitivity, enabling practical and efficient assessment of sugar content.

Recent improvements in F&#246;rster resonance energy transfer (FRET) sensors have enabled their use to detect various small molecules including ions and ...

Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays

As with small molecule drug discovery, screening for peptide agonists requires the serial dilution of peptides to produce concentration-response curves. Screening peptides affords an additional layer of complexity as conventional tip-based sample handling methods expose peptides to a large surface area of plasticware, providing an increased opportunity for peptide loss via adsorption. Preventing excessive exposure to plasticware reduces peptide loss via adherence to plastics and thus minimizes inaccuracies in potency prediction, and we have previously described the benefits of non-contact acoustic dispensing for in vitro high-throughput screening of peptide agonists1. Here we discuss a fully integrated automation solution for non-contact acoustic preparation of peptide serial dilutions in microtiter plates utilizing the example of screening for peptide agonists at the mouse glucagon-like peptide-1 receptor (GLP-1R). Our methods allow for high-throughput cell-based assays to screen for agonists and are easily scalable to support increased sample throughput, or to allow for increased numbers of assay plate copies (e.g., for a panel of more target cell lines).

Peptide adsorption to plasticware during traditional tip-based serial dilutions can significantly impact potency determination and confound the understanding of structure-activity relationships used for lead identification and lead optimization phases of drug discovery. Here methods for automated acoustic non-contact serial dilution of peptide samples are described.

As with small molecule drug discovery, screening for peptide agonists requires the serial dilution of peptides to produce concentration-response curves. ...

Sample Preparation for Mass Spectrometry-based Identification of RNA-binding Regions

Noncoding RNAs play important roles in several nuclear processes, including regulating gene expression, chromatin structure, and DNA repair. In most cases, the action of noncoding RNAs is mediated by proteins whose functions are in turn regulated by these interactions with noncoding RNAs. Consistent with this, a growing number of proteins involved in nuclear functions have been reported to bind RNA and in a few cases the RNA-binding regions of these proteins have been mapped, often through laborious, candidate-based methods.
Here, we report a detailed protocol to perform a high-throughput, proteome-wide unbiased identification of RNA-binding proteins and their RNA-binding regions. The methodology relies on the incorporation of a photoreactive uridine analog in the cellular RNA, followed by UV-mediated protein-RNA crosslinking, and mass spectrometry analyses to reveal RNA-crosslinked peptides within the proteome. Although we describe the procedure for mouse embryonic stem cells, the protocol should be easily adapted to a variety of cultured cells.

We describe a protocol to identify RNA-binding proteins and map their RNA-binding regions in live cells using UV-mediated photocrosslinking and mass spectrometry.

Noncoding RNAs play important roles in several nuclear processes, including regulating gene expression, chromatin structure, and DNA repair. In most ...

Rapid Fluorescence-based Characterization of Single Extracellular Vesicles in Human Blood with Nanoparticle-tracking Analysis

Extracellular vesicles (EVs), including exosomes, are specialized membranous nano-sized vesicles found in bodily fluids that are constitutively released from many cell types and play a pivotal role in regulating cell-cell communication and a diverse range of biological processes. Many different methods for the characterization of EVs have been described. However, most of these methods have the disadvantage that the preparation and characterization of the samples are very time-consuming, or it is extremely difficult to analyze specific markers of interest due to their small size and due to the lack of discrete populations. While methods for analysis of EVs have been considerably improved over the last decade, there is still no standardized method for characterization of single EVs. Here, we demonstrate a semi-automated method for characterization of single EVs by fluorescence-based nanoparticle-tracking analysis. The protocol that is presented addresses the common problem of many researchers in this field and provides the complete workflow for rapid isolation of EVs and characterization with PKH67, a general cell membrane linker, as well as with specific surface markers such as CD63, CD9, vimentin, and lysosomal-associated membrane protein 1 (LAMP-1). The presented results show a high level of reproducibility, as confirmed by other methods, such as Western blotting. In the conducted experiments, we exclusively used EVs isolated from human serum samples, but this method is also suitable for plasma or other body fluids and can be adjusted for characterization of EVs from cell culture supernatants. Irrespective of the future progress of research on EV biology, the protocol that is presented here provides a rapid and reliable method for rapid characterization of single EVs with specific markers.

In this protocol, we describe the complete workflow for rapid isolation of extracellular vesicles from human whole blood and characterization of specific markers by fluorescence-based nanoparticle-tracking analysis. The presented results show a high level of reproducibility and can be adjusted to cell culture supernatants.

Extracellular vesicles (EVs), including exosomes, are specialized membranous nano-sized vesicles found in bodily fluids that are constitutively released ...

Site-Directed Mutagenesis for In Vitro and In Vivo Experiments Exemplified with RNA Interactions in Escherichia Coli

Site-directed mutagenesis is a technique used to introduce specific mutations in DNA to investigate the interaction between small non-coding ribonucleic acid (sRNA) molecules and target messenger RNAs (mRNAs). In addition, site-directed mutagenesis is used to map specific protein binding sites to RNA. A 2-step and 3-step PCR based introduction of mutations is described. The approach is relevant to all protein-RNA and RNA-RNA interaction studies. In short, the technique relies on designing primers with the desired mutation(s), and through 2 or 3 steps of PCR synthesizing a PCR product with the mutation. The PCR product is then used for cloning. Here, we describe how to perform site-directed mutagenesis with both the 2- and 3-step approach to introduce mutations to the sRNA, McaS, and the mRNA, csgD, to investigate RNA-RNA and RNA-protein interactions. We apply this technique to investigate RNA interactions; however, the technique is applicable to all mutagenesis studies (e.g., DNA-protein interactions, amino-acid substitution/deletion/addition). It is possible to introduce any kind of mutation except for non-natural bases but the technique is only applicable if a PCR product can be used for downstream application (e.g., cloning and template for further PCR).

Site-Directed Mutagenesis for In Vitro and In Vivo Experiments Exemplified with RNA Interactions in Escherichia Coli

Site-directed mutagenesis is a technique used to introduce specific mutations in deoxyribonucleic acid (DNA). This protocol describes how to do site-directed mutagenesis with a 2-step and 3-step polymerase chain reaction (PCR) based approach, which is applicable to any DNA fragment of interest.

Site-directed mutagenesis is a technique used to introduce specific mutations in DNA to investigate the interaction between small non-coding ribonucleic ...

Translating Ribosome Affinity Purification (TRAP) for RNA Isolation from Endothelial Cells In Vivo

Many studies have been limited to using in vitro cellular assays and whole tissues or isolating of specific cell types from animals for in vitro analysis of transcriptome and gene expression by qPCR and RNA sequencing. Comprehensive transcriptome and gene expression analysis of specific cell types in complex tissues and organs will be critical to understand cellular and molecular mechanisms by which genes are regulated and their association with tissue homeostasis and organ functions. In this article, we demonstrate the methodology for isolation of ribosome-bound RNA directly in vivo in the vascular endothelia of animal lungs as an example. The specific materials and procedures for tissue processing and RNA purification will be described, including the assessment of RNA quality and yield as well as real time qPCR for arteriogenic gene assays. This approach, known as translating ribosome affinity purification (TRAP) technique, can be utilized for characterization of gene expression and transcriptome analysis of certain cell types directly in vivo in any specific type in complex tissues.

Translating Ribosome Affinity Purification TRAP for RNA Isolation from Endothelial Cells In Vivo

We present an approach to purify ribosome-bound mRNA from vascular endothelial cells (ECs) directly in mouse brain, lung and heart tissues via EC-specific genetic tag of enhanced green fluorescence protein (EGFP)in ribosomes in combination with RNA purification.

Many studies have been limited to using in vitro cellular assays and whole tissues or isolating of specific cell types from animals for in vitro analysis ...

Monitoring Protein-RNA Interaction Dynamics In Vivo at High Temporal Resolution Using &#967;CRAC

The interaction between RNA-binding proteins (RBPs) and their RNA substrates exhibits fluidity and complexity. Within its lifespan, a single RNA can be bound by many different RBPs that will regulate its production, stability, activity, and degradation. As such, much has been done to understand the dynamics that exist between these two types of molecules. A particularly important breakthrough came with the emergence of &#8216;cross-linking and immunoprecipitation&#8217; (CLIP). This technique allowed stringent investigation into which RNAs are bound by a particular RBP. In short, the protein of interest is UV cross-linked to its RNA substrates in vivo, purified under highly stringent conditions, and then the RNAs covalently cross-linked to the protein are converted into cDNA libraries and sequenced. Since its conception, many derivative techniques have been developed in order to make CLIP amenable to particular fields of study. However, cross-linking using ultraviolet light is notoriously inefficient. This results in extended exposure times that make the temporal study of RBP-RNA interactions impossible. To overcome this issue, we recently designed and built much-improved UV irradiation and cell harvesting devices. Using these new tools, we developed a protocol for time-resolved analyses of RBP-RNA interactions in living cells at high temporal resolution: Kinetic CRoss-linking and Analysis of cDNAs (&#967;CRAC). We recently used this technique to study the role of yeast RBPs in nutrient stress adaptation. This manuscript provides a detailed overview of the &#967;CRAC method and presents recent results obtained with the Nrd1 RBP.

Kinetic cross-linking and analysis of cDNA is a method that allows investigation of the dynamics of protein-RNA interactions in living cells at high temporal resolution. Here the protocol is described in detail, including the growth of yeast cells, UV cross-linking, harvesting, protein purification, and next generation sequencing library preparation steps.

The interaction between RNA-binding proteins (RBPs) and their RNA substrates exhibits fluidity and complexity. Within its lifespan, a single RNA can be ...

Rapid and Cost-Effective RNA Extraction of Rat Pancreatic Tissue

Regardless of the extraction method, optimized RNA extraction of tissues and cell lines are carried out in four stages: 1) homogenization, 2) effective denaturation of proteins from RNA, 3) ribonuclease inactivation, and 4) removal of contamination from DNA, proteins, and carbohydrates. However, it is very laborious to maintain the integrity of RNA when there are high levels of RNase in the tissue. Spontaneous autolysis makes it very difficult to extract RNA from pancreatic tissue without damaging it. Thus, a practical RNA extraction method is needed to maintain the integrity of pancreatic tissues during the extraction process. An experimental and comparative study of existing protocols was carried out by obtaining 20-30 mg of rat pancreatic tissues in less than 2 minutes and extracting the RNA. The results were assessed by electrophoresis. The experiments were carried out three times for generalization of the results. Immersing pancreatic tissue in RNA stabilization reagent at -80 &#176;C for 24 h yielded high integrity RNA, when the RNA extraction reagent was used as the reagent. The results obtained were comparable to the results obtained from commercial kits with spin column bindings.

The purity and integrity of the isolated RNA is a vital step in RNA dependent assays. Here, we present a practical, rapid, and inexpensive method to extract RNA from a small quantity of undamaged pancreatic tissue.

Regardless of the extraction method, optimized RNA extraction of tissues and cell lines are carried out in four stages: 1) homogenization, 2) effective ...

MS2-Affinity Purification Coupled with RNA Sequencing in Gram-Positive Bacteria

Although small regulatory RNAs (sRNAs) are widespread among the bacterial domain of life, the functions of many of them remain poorly characterized notably due to the difficulty of identifying their mRNA targets. Here, we described a modified protocol of the MS2-Affinity Purification coupled with RNA Sequencing (MAPS) technology, aiming to reveal all RNA partners of a specific sRNA in vivo. Broadly, the MS2 aptamer is fused to the 5&#8217; extremity of the sRNA of interest. This construct is then expressed in vivo, allowing the MS2-sRNA to interact with its cellular partners. After bacterial harvesting, cells are mechanically lysed. The crude extract is loaded into an amylose-based chromatography column previously coated with the MS2 protein fused to the maltose binding protein. This enables the specific capture of MS2-sRNA and interacting RNAs. After elution, co-purified RNAs are identified by high-throughput RNA sequencing and subsequent bioinformatic analysis. The following protocol has been implemented in the Gram-positive human pathogen Staphylococcus aureus and is, in principle, transposable to any Gram-positive bacteria. To sum up, MAPS technology constitutes an efficient method to deeply explore the regulatory network of a particular sRNA, offering a snapshot of its whole targetome. However, it is important to keep in mind that putative targets identified by MAPS still need to be validated by complementary experimental approaches.

MAPS technology has been developed to scrutinize the targetome of a specific regulatory RNA in vivo. The sRNA of interest is tagged with a MS2 aptamer enabling the co-purification of its RNA partners and their identification by RNA sequencing. This modified protocol is particularly suited for Gram-positive bacteria.&#160;

Although small regulatory RNAs (sRNAs) are widespread among the bacterial domain of life, the functions of many of them remain poorly characterized ...

Labelling and Visualization of Mitochondrial Genome Expression Products in Baker's Yeast Saccharomyces cerevisiae

Mitochondria are essential organelles of eukaryotic cells capable of aerobic respiration. They contain circular genome and gene expression apparatus. A mitochondrial genome of baker&#8217;s yeast encodes eight proteins: three subunits of the cytochrome c oxidase (Cox1p, Cox2p, and Cox3p), three subunits of the ATP synthase (Atp6p, Atp8p, and Atp9p), a subunit of the ubiquinol-cytochrome c oxidoreductase enzyme, cytochrome b (Cytb), and mitochondrial ribosomal protein Var1p. The purpose of the method described here is to specifically label these proteins with 35S methionine, separate them by electrophoresis and visualize the signals as discrete bands on the screen. The procedure involves several steps. First, yeast cells are cultured in a galactose-containing medium until they reach the late logarithmic growth stage. Next, cycloheximide treatment blocks cytoplasmic translation and allows 35S methionine incorporation only in mitochondrial translation products. Then, all proteins are extracted from yeast cells and separated by polyacrylamide gel electrophoresis. Finally, the gel is dried and incubated with the storage phosphor screen. The screen is scanned on a phosphorimager revealing the bands. The method can be applied to compare the biosynthesis rate of a single polypeptide in the mitochondria of a mutant yeast strain versus the wild type, which is useful for studying mitochondrial gene expression defects. This protocol gives valuable information about the translation rate of all yeast mitochondrial mRNAs. However, it requires several controls and additional experiments to make proper conclusions.

Labelling and Visualization of Mitochondrial Genome Expression Products in Baker's Yeast Saccharomyces cerevisiae

Baker&#8217;s yeast mitochondrial genome encodes eight polypeptides. The goal of the current protocol is to label all of them and subsequently visualize them as separate bands.

Mitochondria are essential organelles of eukaryotic cells capable of aerobic respiration. They contain circular genome and gene expression apparatus. A ...